from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2873/mpt83

LFCtreatmentdescriptionclass of inhibitor

0.880

Amikacinug/mL Amikacintranslation

1.658

Cap5-10ug/mL Capreomycintranslation

2.225

Rox10-50 ug/mL Roxithromycintranslation

0.291

SM2-5 ug/mL Streptomycintranslation

-0.751

Tet5-10 ug/mL Tetracyclinetranslation

0.122

Rif0.2-5ug/mL Rifampicintranscription

-0.411

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.550

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.811

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.660

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.658

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.400

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.909

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.402

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.779

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.308

Nigericin50 uM Nigericinrespiration

-0.081

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.193

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.371

menadione6-10 ug/mL Menadionerespiration

-0.286

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.175

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.714

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.506

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.428

NRP_1Non-replicating persistence stage 1dosRassociated

-0.379

Amp0.2mg/mL AmpicillincellWall

0.014

Cephalexin20-100 ug/mL CephalexincellWall

0.057

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.085

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.088

EMB10-20 ug/mL EthambutolcellWall

0.651

Eta12-40 ug/mL EthionamidecellWall

-0.271

INH0.2-0.4 ug/mL IsoniazidcellWall

0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.958

BZA0.12 mg/mL BenzamidearomaticAmides

0.152

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.019

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.340

H2O24 mM hydrogen peroxideDNAdamaging

0.005

Levo10 ug/mL LevofloxacinDNAdamaging

-0.152

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.254

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.506

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.453

Antimycin12.5-50 ug/mL Antimycin A?

-1.066

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.007

PA_110-50 ug/mL Antitubercular compound PA-1?

0.137

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.217

PA8240.2-2 ug/mL PA-824?

0.616

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.256

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.521

Verapamil50 uM Verapamil?

-1.258

mercaptoethanol2 mM 2-Mercaptoethanol?

0.671

methoxatin10-20 ug/mL Methoxatin?